Although not fully understood at present, work by Du and colleagues points towards a role of CPT1A in contributing to ccRCC development as its re-establishment into VHL-defective cells blocks lipid accumulation and, most importantly, tumorigenesis [94]. The gene discussed is CPT1A; the disease is nonpapillary renal cell carcinoma.